Could a simple supplement soothe IBS?
NCT ID NCT07039747
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a dietary supplement called DIELEN Protect, which contains glutamine and marine peptides, can ease symptoms of irritable bowel syndrome (IBS). One hundred adults with moderate to severe IBS will take either the supplement or a placebo for 8 weeks. Researchers will measure changes in symptom severity, quality of life, and gut bacteria to see if the supplement helps.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DIELEN® Protect (glutamine and Gabolysat® marine peptides)
What this could lead to
If it works, this could offer a natural supplement option to reduce IBS severity and improve quality of life.
What could go wrong
This is an early phase 2 trial with only 100 participants, so results may not apply to everyone. The supplement may not outperform placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
CHU de Rouen
RECRUITINGRouen, France, France
Contact Phone: •••-•••-•••• Email: •••••@•••••